71 results on '"Jessen, Bart"'
Search Results
52. Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma
53. The Contribution of Lysosomotropism to Autophagy Perturbation
54. Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits
55. A tyrosine kinase inhibitor-induced myocardial degeneration in rats through off-target phosphodiesterase inhibition
56. Retina Expression and Cross-Species Validation of Gene Silencing by PF-655, a Small Interfering RNA Against RTP801 for the Treatment of Ocular Disease
57. Off‐target immune cell toxicity caused by AG‐012986, a pan‐CDK inhibitor, is associated with inhibition of p38 MAPK phosphorylation
58. Evaluation of the effects of a VEGFR-2 inhibitor compound on alanine aminotransferase gene expression and enzymatic activity in the rat liver
59. Abstract A10: Off-target toxicity in white blood cells by AG-012986, a pan-CDK inhibitor, is mediated through inhibition of p38 MAPK signaling pathway
60. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model
61. Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy
62. Toxicogenomic Analysis of Cardiotoxicity in Rats
63. Antisense inhibition of 11βhydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model
64. Peripheral white blood cell toxicity induced by broad spectrum cyclin-dependent kinase inhibitors
65. Inhibiting matrix metalloproteinases with prinomastat produces abnormalities in fetal growth and development in rats
66. Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts
67. Functional AP1 and CRE response elements in the human keratinocyte transglutaminase promoter mediating Whn suppression
68. Keratinocyte Transglutaminase Promoter Analysis
69. Off-target immune cell toxicity caused by AG-012986, a pan-CDK inhibitor, is associated with inhibition of p38 MAPK phosphorylation.
70. Evaluation of the effects of a VEGFR-2 inhibitor compound on alanine aminotransferase gene expression and enzymatic activity in the rat liver
71. Lysosome Impairment, Phagocytosis Inhibition and Retinopathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.